Taha Merghoub, PhD and AASA president was featured in a Science Daily article for his contribution in developing a mathematical model that predicts immunotherapy success.
Read full article here (Link)
- Marta Łuksza, Nadeem Riaz, Vladimir Makarov, Vinod P. Balachandran, Matthew D. Hellmann, Alexander Solovyov, Naiyer A. Rizvi, Taha Merghoub, Arnold J. Levine, Timothy A. Chan, Jedd D. Wolchok, Benjamin D. Greenbaum. A neoantigen fitness model predicts tumour response to checkpoint blockade immunotherapy. Nature, 2017; DOI: 10.1038/nature24473
- Vinod P. Balachandran et al. Identification of unique neoantigen qualities in long-term survivors of pancreatic cancer. Nature, 2017; DOI: 10.1038/nature24462